Saol is dedicated to developing and commercializing therapeutics for the central nervous system (CNS), orphan diseases, and conditions with high unmet medical need.  

Eyevance is committed to developing and commercializing innovative and impactful ophthalmic products that enable optimal vision, better quality of life, and address significant unmet medical needs.

Meridien Research’s mission is to provide consistent, high-quality clinical research in a professional, ethical and timely manner to residents of Central Florida via six site locations.

Sebela is committed to developing and commercializing drugs that bring meaningful value to patients affected by gastrointestinal, dermatological, and women’s health diseases.